Precipio (NASDAQ:PRPO) Posts Quarterly Earnings Results

Precipio (NASDAQ:PRPO) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, Zacks reports. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%.

Precipio Price Performance

PRPO stock traded down $0.48 during midday trading on Thursday, hitting $6.18. 4,584 shares of the stock were exchanged, compared to its average volume of 7,975. The stock has a market cap of $9.16 million, a price-to-earnings ratio of -3.38 and a beta of 1.37. Precipio has a fifty-two week low of $4.31 and a fifty-two week high of $10.74. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.73. The stock’s 50-day moving average price is $7.12 and its 200-day moving average price is $6.49.

About Precipio

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.